SCHEMBL28468356

SCHEMBL28468356

CNC(=O)c1ccc(C)c(-n2c(CC(=O)OC)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1

nearest known ligand 0.83

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 20/20 0.83
ROCK2 O75116 1/20 0.79
MAPK12 P53778 1/20 0.79
MAPK11 Q15759 1/20 0.79
STRADA Q7RTN6 1/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4382895 0.91 MAPK14 (1.00) MAPK14ROCK2MAPK12MAPK11STRADA
SCHEMBL29594309 0.91 MAPK14 (1.00) MAPK14ROCK2MAPK12MAPK11STRADA
SCHEMBL5862335 0.89 MAPK14 (0.88) MAPK14ROCK2MAPK12MAPK11STRADA
SCHEMBL29593506 0.89 MAPK14 (0.88) MAPK14ROCK2MAPK12MAPK11STRADA
SCHEMBL4384604 0.89 MAPK14 (0.83) MAPK14ROCK2MAPK12MAPK11STRADA
Ph-797804 SCHEMBL29351545 0.88 MAPK14 (1.00) MAPK14ROCK2MAPK12MAPK11STRADA
Ph-797804 SCHEMBL29527304 0.88 MAPK14 (1.00) MAPK14ROCK2MAPK12MAPK11STRADA
Ph-797804 SCHEMBL2015676 0.88 MAPK14 (1.00) MAPK14ROCK2MAPK12MAPK11STRADA
SCHEMBL6506012 0.83 MAPK14 (0.83) MAPK14ROCK2MAPK12MAPK11STRADA
SCHEMBL6473101 0.83 MAPK14 (0.90) MAPK14ROCK2MAPK12MAPK11STRADA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114748622-A P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD 弗尔康医疗公司 2022-07-15 CN disclosed
CN-114732910-A P38 kinase inhibitor reduces DUX4 and downstream gene expression for treatment of FSHD 弗尔康医疗公司 2022-07-12 CN disclosed
CN-111601593-B P38 kinase inhibitor reduces DUX4 and downstream gene expression for treatment of FSHD 弗尔康医疗公司 2022-04-15 CN disclosed
CN-111601593-A P38 kinase inhibitor reduces DUX4 and downstream gene expression for treatment of FSHD 弗尔康医疗公司 2020-08-28 CN disclosed